Concorde Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Hold
38,100
0.33% 65
2025
Q4
$752K Hold
38,100
0.3% 72
2025
Q3
$621K Buy
+38,100
New +$565K 0.26% 84
2025
Q1
$603K Hold
32,520
0.32% 46
2024
Q4
$366K Hold
32,520
0.19% 89
2024
Q3
$384K Sell
32,520
-23,500
-42% -$222K 0.22% 85
2024
Q2
$438K Sell
56,020
-600
-1% -$3.92K 0.27% 68
2024
Q1
$281K Buy
56,620
+33,640
+146% +$215K 0.19% 103
2023
Q4
$198K Sell
22,980
-10,800
-32% -$79K 0.13% 148
2023
Q3
$234K Hold
33,780
0.21% 120
2023
Q2
$194K Hold
33,780
0.18% 119
2023
Q1
$215K Sell
33,780
-4,000
-11% -$38.1K 0.25% 71
2022
Q4
$444K Sell
37,780
-10,600
-22% -$129K 0.4% 62
2022
Q3
$573K Sell
48,380
-14,000
-22% -$204K 0.64% 49
2022
Q2
$712K Sell
62,380
-3,200
-5% -$33.8K 1.07% 26
2022
Q1
$736K Sell
65,580
-3,000
-4% -$27K 0.49% 64
2021
Q4
$964K Buy
+68,580
New +$1.2M 0.58% 62

Other funds holding ALHC

Concorde Asset Management's ALHC Position: Q1 2026 in Review

Concorde Asset Management held its Alignment Healthcare (ALHC) position steady in Q1 2026 at 38,100 shares worth $671K. The position accounts for 0.33% of the portfolio, ranked #65.

Concorde Asset Management first reported a position in ALHC in Q4 2021 and has held it in 17 quarters since. The position peaked at $964K in Q4 2021. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Concorde Asset Management held 38,100 shares of Alignment Healthcare worth $671K as of Q1 2026.
  • Concorde Asset Management left its Alignment Healthcare share count unchanged in Q1 2026.
  • Alignment Healthcare made up 0.33% of Concorde Asset Management's portfolio in Q1 2026, its #65 holding.
  • Concorde Asset Management first reported a position in Alignment Healthcare in Q4 2021 and has held it in 17 quarters since.
  • Concorde Asset Management's Alignment Healthcare position peaked at $964K in Q4 2021.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.